Market PositionWith a second CPT code now in place, integration into diagnostic workflows at leading institutions, and a continuing flow of publications, the company is well-positioned to drive further adoption and grow revenues.
Product DevelopmentNew versions of VIA and Solve software enhance capabilities, part of Bionano's strategy to broaden its utilization by enhancing software capabilities that streamline data reporting and analysis for OGM.
Scientific ValidationA new quarterly record of 119 peer-reviewed publications highlighting the utilization of OGM was achieved.